Torthaí cuardaigh - Karl Kieburtz
- 1 - 20 toradh as 59 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease de réir Karl Kieburtz
Foilsithe / Cruthaithe 2010Artigo -
2
The relationship between uric acid levels and Huntington's disease progression de réir Peggy Auinger, Karl Kieburtz, Michael McDermott
Foilsithe / Cruthaithe 2010Artigo -
3
A review of disease progression models of Parkinson's disease and applications in clinical trials de réir Charles S. Venuto, Nicholas B. Potter, E. Ray Dorsey, Karl Kieburtz
Foilsithe / Cruthaithe 2016Revisão -
4
The relationship between CAG repeat length and clinical progression in Huntington's disease de réir Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael McDermott
Foilsithe / Cruthaithe 2008Artigo -
5
Levodopa and the Progression of Parkinson's Disease de réir Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, Kenneth Marek
Foilsithe / Cruthaithe 2004Artigo -
6
Moving Parkinson care to the home de réir E. Ray Dorsey, Floris P. Vlaanderen, Lucien JLPG Engelen, Karl Kieburtz, William Zhu, Kevin Biglan, Marjan J. Faber, Bastiaan R. Bloem
Foilsithe / Cruthaithe 2016Revisão -
7
Prevalence of dementia in rural China: impact of age, gender and education de réir Dao Zhou, Ching‐Fen Wu, Haitao Qi, Jin‐Hu Fan, X. D. Sun, Peter G. Como, You‐Lin Qiao, Lu Zhang, Karl Kieburtz
Foilsithe / Cruthaithe 2006Artigo -
8
Trinucleotide repeat length and progression of illness in Huntington's disease. de réir Karl Kieburtz, Marcy E. MacDonald, Chiu-Yang Shih, Andrew Feigin, Kim Steinberg, Kathy Bordwell, Carol Zimmerman, Jayalakshmi Srinidhi, Jenny Sotack, James F. Gusella
Foilsithe / Cruthaithe 1994Artigo -
9
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort de réir Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M. Tanner, Danna Jennings, Karl Kieburtz, Lana M. Chahine, Kenneth Marek
Foilsithe / Cruthaithe 2017Artigo -
10
The Idiopathic Intracranial Hypertension Treatment Trial de réir Deborah I. Friedman, Michael McDermott, Karl Kieburtz, Mark J. Kupersmith, Ann Stoutenburg, John L. Keltner, Steven E. Feldon, Eleanor Schron, James J. Corbett, Michael Wall
Foilsithe / Cruthaithe 2014Artigo -
11
The Idiopathic Intracranial Hypertension Treatment Trial de réir Michael Wall, Mark J. Kupersmith, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Michael McDermott
Foilsithe / Cruthaithe 2014Artigo -
12
Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss de réir Michael Wall, Michael McDermott, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Mark J. Kupersmith
Foilsithe / Cruthaithe 2014Artigo -
13
Results of the citalopram to enhance cognition in Huntington disease trial de réir Leigh J. Beglinger, William Adams, Douglas R. Langbehn, Jess G. Fiedorowicz, Ricardo E. Jorge, Kevin Biglan, John N. Caviness, Blair Olson, Robert G. Robinson, Karl Kieburtz, Jane S. Paulsen
Foilsithe / Cruthaithe 2013Artigo -
14
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease de réir Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs
Foilsithe / Cruthaithe 2014Artigo -
15
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease de réir Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs
Foilsithe / Cruthaithe 2013Artigo -
16
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease de réir Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset, Fabrizio Stocchi, Marie Saint‐Hilaire, Aaron Ellenbogen, Mika Leinonen, Neil B. Hampson, Tia DeFeo-Fraulini, Martin I. Freed, Karl Kieburtz
Foilsithe / Cruthaithe 2016Artigo -
17
Trichloroethylene: An Invisible Cause of Parkinson’s Disease? de réir E. Ray Dorsey, Maryam Zafar, Samantha E. Lettenberger, Meghan Pawlik, Dan Kinel, Myrthe Frissen, Ruth B. Schneider, Karl Kieburtz, Caroline M. Tanner, Briana R. De Miranda, Samuel M. Goldman, Bastiaan R. Bloem
Foilsithe / Cruthaithe 2023Revisão -
18
HIV-associated cognitive impairment before and after the advent of combination therapy de réir Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein
Foilsithe / Cruthaithe 2002Artigo -
19
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study de réir C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini
Foilsithe / Cruthaithe 2013Artigo -
20
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia de réir Jeffrey Sevigny, Steven M. Albert, Michael McDermott, Justin C. McArthur, Ned Sacktor, Kathy Conant, Giovanni Schifitto, Ola A. Selnes, Yaakov Stern, Daniel McClernon, Donna Palumbo, Karl Kieburtz, Garrett Riggs, Bevin Cohen, Leon G. Epstein, Karen Marder
Foilsithe / Cruthaithe 2004Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Disease
Internal medicine
Parkinson's disease
Pathology
Psychology
Alternative medicine
Placebo
Biology
Cohort
Oncology
Biomarker
Psychiatry
Biochemistry
Neuroscience
Clinical trial
Randomized controlled trial
Cohort study
Dopamine
Gastroenterology
Huntington's disease
Physical therapy
Chemistry
Dopaminergic
Genetics
Pediatrics
Cognition
Confidence interval
Dementia
Physical medicine and rehabilitation